COVID-19 Records

Attachment

Gates Package, p.508 · gates:exh:00167

Page text: p.508 · original PDF

Date
(unknown precision)
Type
attachment · document
Topics
Therapeutics and treatments
NIH E FAR Co abo at n 2013 mcb 1/10/13 NICHD Sherr 75057 Systems analysis and improvement to optimize pMTCT: A cluster randomized Trial Cote d'Ivoire/ Kenya/ Mozambique Aliyu 75075 Optimizing integrated PMTCT services in rural North Central Nigeria Nigeria Yotebeing 75171 Conditional cash transfers to increase uptake and retention of PMTCT services Democratic Republic of Congo Israel-Ballard 75090 Effect of feeding buddies on adherence to WHO PMTCT guidelines in South Africa South Africa Abrams 75163 Mother and infant retention for health (MIR4Health) Kenya Chi 75131 Validation of a community survey methodology formeasuring PMTCT impact Zambia Ezeanolue 75050 Comparative effectiveness of congregation and clinic based approaches to PMTCT Nigeria Davies 75156 Closing the gaps in PMTCT program coverage, early infant diagnosis and treatment South Africa Farquhar 75108 HIV testing and educating male partners to improve maternal and infant outcomes Kenya TOTAL per YEAR $3million PEPFAR Funds $2.5million NICHD Funds $500,000 RFA DA-12-002: HIV/AIDS Implemenation Science Targeting Drug Using Populations: A Collaboration with PEPFAR (R01) NIDA Altice 33679 Expanding Medication Assisted Therapies in Ukraine NIDA Owczarzak 33644 A Novel, Bottom Up Approach to Promote Evidence Based HIV Prevention for IDUs NIDA Goldsamt 33673 Implementation of a Sexual Health Intervention for YMSM in Two Vietnamese Cities NIDA Page 33672 Cambodia Integrated HIV and Drug Prevention Implementation Program NIDA Li 33609 Enhancing the Role of Commune Health Workers in HIV and Drug Control in Vietnam NIDA O'Brien 33671 A Pilot Implementation Project of Methadone and Suboxone for Injecting Drug Users NIDA Woody 33670 Opioid Relaps & HIV Risk: 48 vs. 24 Weeks of ER Injectable Naltrexone Opioid Relaps & HIV Risk: 48 vs. 24 Weeks of ER Injectable Naltrexone No PEPFAR funding was supplied - all of these grants funded through NIDA FOGARTY INTERNATIONAL CENTER Medical Education Partnership Initiative (MEPI) FIC multiple Medical School Training/Education multi ~$10m/yr OGAC multi $6 - 7m/yr FIC